38,000 square foot build-to-suit life sciences facility available in Einstein’s Alley

A newly approved 38,000-square-foot research facility by Mountain Development Corp and Gottesman Real Estate Partners in Roszel Square is being offered as a build-to suit, fully customizable facility for life sciences enterprises seeking to launch or expand their lab and clinical capabilities for developing new therapies to bring to market.

The developers feel the project, which will be located within the Roszel Square development at 19 Roszel Square in the Princeton Route 1 Corridor, said the facility has two possibilities:

· A mid-size life sciences organization could become the sole tenant of the entire 38,000-square-foot facility, with full control over their environment from the lobby to the labs;

· A user could be the lead tenant of just 19,000 square feet but be granted building naming and branding rights.

In either case, the developer said the tenant can have the facility constructed on a customizable basis depending on its development needs.

Princeton Property Partners will serve as the lead broker for the project.

“This is a significant new project that global life sciences companies can take advantage of to enhance and grow their medicine or device research activities and accelerate the pipeline of breakthrough discoveries to meet patient health needs and do so in one of the most recognized and prestigious markets in the world,” Michael Seeve, president of Mountain Development Corp, said.

The two-story development will be designed with every contemporary element specific to lab R&D environments, including lab-level HVAC systems, 16-foot ceiling heights, a freight elevator and service corridor, loading dock, heavy power and floor loads, and a back-up generator for critical functions.

The area, known as Einstein’s Alley, is home to Princeton University, many Fortune 500 and life sciences companies – and the professional firms that service them.

The project will be the second building in the market that Mountain and Gottesman will develop together.